Paradigm Biopharmaceuticals Limited (PAR.AX)

AUD 0.32

(3.23%)

Revenue Summary of Paradigm Biopharmaceuticals Limited

  • Paradigm Biopharmaceuticals Limited's latest annual revenue in 2024 was 65.8 Thousand AUD , up 40.72% from previous year.
  • Paradigm Biopharmaceuticals Limited's latest quarterly revenue in 2024 FY was 65.8 Thousand AUD , up 40.72% from previous quarter.
  • Paradigm Biopharmaceuticals Limited reported a annual revenue of 46.76 Thousand AUD in annual revenue 2023, down -40.98% from previous year.
  • Paradigm Biopharmaceuticals Limited reported a annual revenue of 79.22 Thousand AUD in annual revenue 2022, up 285.52% from previous year.
  • Paradigm Biopharmaceuticals Limited reported a quarterly revenue of 65.8 Thousand AUD for 2024 Q4, down 0.0% from previous quarter.
  • Paradigm Biopharmaceuticals Limited reported a quarterly revenue of 65.8 Thousand AUD for 2024 FY, up 40.72% from previous quarter.

Annual Revenue Chart of Paradigm Biopharmaceuticals Limited (2024 - 2014)

Historical Annual Revenue of Paradigm Biopharmaceuticals Limited (2024 - 2014)

Year Revenue Revenue Growth
2024 65.8 Thousand AUD 40.72%
2023 46.76 Thousand AUD -40.98%
2022 79.22 Thousand AUD 285.52%
2021 20.55 Thousand AUD 0.0%
2020 - AUD -100.0%
2019 2.98 Million AUD 11.24%
2018 2.68 Million AUD 47.12%
2017 1.82 Million AUD 41.28%
2016 1.29 Million AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%

Peer Revenue Comparison of Paradigm Biopharmaceuticals Limited

Name Revenue Revenue Difference
AdAlta Limited 1.73 Million AUD 96.214%
Acrux Limited 5.09 Million AUD 98.708%
Botanix Pharmaceuticals Limited 601.82 Thousand AUD 89.066%
BTC Health Limited 16.36 Thousand AUD -302.2%
Chimeric Therapeutics Limited 7.45 Million AUD 99.118%
Clarity Pharmaceuticals Ltd 11.5 Million AUD 99.428%
Clinuvel Pharmaceuticals Limited 88.17 Million AUD 99.925%
Biome Australia Limited 13 Million AUD 99.494%
Hexima Limited - AUD -Infinity%
Immutep Limited 3.5 Million AUD 98.123%
Memphasys Limited 60 Thousand AUD -9.667%
Neuren Pharmaceuticals Limited 231.92 Million AUD 99.972%
Noxopharm Limited 2.4 Million AUD 97.259%
Prescient Therapeutics Limited 3.71 Million AUD 98.228%
Race Oncology Limited 4 Million AUD 98.356%
Radiopharm Theranostics Limited 299.22 Thousand AUD 78.01%
Starpharma Holdings Limited 8.28 Million AUD 99.206%
Tissue Repair Ltd 152.24 Thousand AUD 56.779%
Biotron Limited - AUD -Infinity%
Alterity Therapeutics Limited 4.01 Million AUD 98.363%
CSL Limited 22.41 Billion AUD 100.0%
EZZ Life Science Holdings Limited 66.44 Million AUD 99.901%
Anatara Lifesciences Ltd - AUD -Infinity%
Bio-Gene Technology Limited 18.32 Thousand AUD -259.17%
Zelira Therapeutics Limited 94.95 Thousand AUD 30.702%
Patrys Limited 1.39 Million AUD 95.28%
Orthocell Limited 5.31 Million AUD 98.762%
Imugene Limited - AUD -Infinity%
PYC Therapeutics Limited 22.05 Million AUD 99.702%
Proteomics International Laboratories Limited 892.14 Thousand AUD 92.625%
Cynata Therapeutics Limited 2.31 Million AUD 97.158%
Arovella Therapeutics Limited 17 Thousand AUD -287.059%
Nanollose Limited 12.5 Thousand AUD -426.358%
Invex Therapeutics Ltd 1.21 Million AUD 94.572%
NeuroScientific Biopharmaceuticals Limited - AUD -Infinity%
Amplia Therapeutics Limited 4.45 Million AUD 98.522%
Island Pharmaceuticals Limited 1.25 Million AUD 94.743%
Nyrada Inc. - AUD -Infinity%
Telix Pharmaceuticals Limited 496.65 Million AUD 99.987%
Dimerix Limited 583.47 Thousand AUD 88.723%
PharmAust Limited - AUD -Infinity%
AnteoTech Limited 460.39 Thousand AUD 85.708%
Recce Pharmaceuticals Ltd - AUD -Infinity%
Avecho Biotechnology Limited 473.55 Thousand AUD 86.105%
Actinogen Medical Limited 9.93 Million AUD 99.337%
Immuron Limited 4.9 Million AUD 98.658%
Argenica Therapeutics Limited 2.59 Million AUD 97.467%